Inclusion Criteria:

- Subject is able to give written consent

- Females >21 years of age

- At least one breast diagnosed with cancer or mastectomy due to a positive BRCA gene
mutation test.

- Subject is indicated for bilateral nipple-sparing mastectomy surgery with immediate
breast reconstruction

- Subject is able to comply with the study protocol

Exclusion Criteria:

- Primary tumor(s) located within 2cm of the areola margins

- Inability to perform follow up assessments

- Radiation treatment within 30 days of surgery

- Dermabond or other forms of surgical glue is used in the peri-areola region

- Subjects who are known to be allergic to any of the test product(s) or any component
of the test product(s)

- Women who are pregnant

- Subjects who have been treated with an investigational drug or device within the past
30 days prior to enrollment